Understanding and predicting dose dependent and idiosyncratic events
12-07-2016-1330-Paul-Watkins-YES
12-07-2016-1330-Paul-Watkins-YES
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Posted: 5:17 p.m. Friday, Nov. 4, 2016<br />
The Associated Press<br />
WASHINGTON —<br />
Cempra is one of a h<strong>and</strong>ful of drugmakers developing new<br />
antibiotics amid growing bacterial resistance to decades-old<br />
drugs like penicillin.<br />
On Wednesday Cempra shares plunged more than 60<br />
percent after the FDA posted an online review highlighting<br />
irregular liver enzyme measurements reported with the drug,<br />
called solithromycin……..<br />
Copyright The Associated Press